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Oxygen is necessary for most life on our planet, and the ability to sense and adapt to 
changes in oxygen concentration is required for life to persist. Hypoxia is defined as the 
deficiency of oxygen reaching body tissues. In mammals, tissue response to hypoxia is 
integral to a wide variety of processes, including the building of vasculature, heart disease, 
and tumor angiogenesis. The transcriptional response to hypoxia is largely regulated by 
hypoxia inducible factors (HIFs). These HIFs are heterodimeric, consisting of an oxygen-
sensing alpha subunit and anon-oxygen-sensing beta subunit. When oxygen levels are 
normal, HIF-1 alpha is hydroxylated by EGLN/PHD prolyl hydroxylases. This modification 
targets HIF-1 alpha for degradation via the von Hippel Lindau tumor suppressor protein 
(VHL). Oxygen is an essential substrate for EGLN/PHD activity, and during hypoxia, the 
HIF-1 alpha subunit is not hydroxylated, and is, therefore, stable. HIF-1 alpha translocates to 
the nucleus, where it regulates the transcription of downstream genes. This pathway is 
evolutionarily conserved between mammals and Caeno~habditis elegans, where genes 
encode homologs of HIF-1 alpha, PHD/EGLN and VHL as HIF- l , EGL-9 and VHL-1, 
respectively. 
Working on C. elegans, our lab is attempting to find negative regulators of the HIF-1 
pathway by performing a forward genetic screen and identifying mutations that cause 
increased expression of aHIF-1-responsive reporter gene. I have shown progress in mapping 
these potential positive regulator mutations and in attempting to prioritize mutations obtained 
in the screen by molecular analysis of various RNA transcripts and protein levels. In 
addition, I tested a hypothesis that a novel ubiquitin-degradation pathway that is independent 





Importance of regulation of oxygen tensions in cells 
Many metazoans can persist in varying degrees of low oxygen, but all known 
multicellular animals require oxygen to complete their life cycle (Fenchel and Findlay 
1995). This oxygen is used to complete processes such as oxidative phosphorylation and 
synthesis of ATP (Saraste 1999; Lopez-Barneo et al. 2001). Therefore, anoxic conditions 
can result in the death of most free-living organisms within 24 hours without oxygen (Clegg 
1997). On the other side of the scale, hyperoxic conditions can result in an increased 
production of free radicals and hydrogen peroxide that disrupt metabolic processes by 
causing damage to the mitochondria and inactivating metabolic enzymes (Gille and Joenje 
1992). Atmospheric air has a tension of 21 kPa oxygen. Tissue oxygen levels are 
heterogeneous, varying anywhere from 1-5% (Silver and Erecinska 1998). The 
microenvironment in which mitochondria operate has a tension of less than 0.2 kPa oxygen, 
but mitochondria can maintain respiration in tensions as low as 0.004 kPa (Lu et. al 1999; 
Atkinson 1980; Gnaiger et al. 1998; Richmond et al. 1997). 
The discrepancy between atmospheric and tissue tensions can be explained by the 
large distance oxygen must travel to reach cells (Gnaiger 2001). Mitochondria consumes 
oxygen rapidly in order to complete aerobic respiration, so diffusion plus consumption issues 
can cause oxygen concentrations to become compromised when oxygen supplies are limited 
(Denny 1993 and Schmidt-Nielsen 1997). Since aerobic metabolism is required for survival 
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of most organisms, a variety of mechanisms are in place to help the organism live in 
compromised oxygen conditions. Some of these include: metabolic depression (Clegg, 
1997), increased rates of glycolytic flux (Baumgartl et al. 1994), and the upregulation of 
genes such as heat shock proteins and other genes that protect cells from environmental 
stresses (Ko and Prives 1996; Ratcliffe et al. 1998). 
Medical implications of lack of oxygen homeostasis 
HIF plays central roles in cardiovascular disease and in tumor growth. when illness 
or injury disrupts blood flow, cells become hypoxic. Increased HIF-1 function is required for 
survival of cells, tissues, and ultimately the individual. The center of a solid tumor can be 
severely hypoxic. Transcription of HIF downstream target genes holds a very important role 
in the response to hypoxia. One of the downstream genes is vascular endothelial growth 
factor (VEGF), which plays an important role in angiogenesis {Ferrara, 1999) and VEGF 
mRNA levels increase dramatically when the cell is exposed to hypoxia (Gerber et ai. 1997, 
Carmeliet et al. 1998, Iyer et al. 1998, Ryan et al. 1998, Dor et al. 2001). This increased 
expression of VEGF leads to the establishment of blood supplies in solid tumors, enabling 
tumor growth and development (Semenza, 2000). 
HIF-1 activity is increased in human cancers as a result of the physiological induction 
of HIF-1 alpha in response to intratumoural hypoxia and as a result of genetic alterations that 
activate oncogenes and inactivate tumour suppressor genes. The loss of p53 function leads to 
an increase in HIF-1 alpha and VEGF expression in one of the p53 cancer pathways (Ravi et 
al. 2000). Conversely, it has been shown that mutations in oncogenes, such as v-SRC, can 
induce the expression of HIF-1 alpha protein, I-IIF-1 transcriptional activity, and the 
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transcription of downstream targets such as VEGF (Jiang et al. 1997). HIF-1 target genes are 
being studied in order to find a clear molecular basis for tumor progression. Some known 
metabolic enzymes such as Hexokinase 1, IGF-2 and TGF beta regulate energy usage and 
cell proliferationlviability in the presence of lowered oxygen. Other downstream genes, 
VEGF and Heme Oxygenase 1, contribute to vascular remodeling and angiogenesis. Still 
others, like Erythropoeitin and Transferrin are involved in iron homeostasis and metabolism 
(Iyer et al. 1998). The distinct processes of energy metabolism, ce11 proliferation, iron 
homeostasis, and angiogenesis are all protected in hypoxia to allow for tissue and organism 
survival (Ravi et al 2000). Since tumors often have to overcome hypoxia to grow, strategies 
targeting the increased HIF-1 expression in these tumors are currently underway (Dachs et al 
1997, Brown 2000, Shibata et al. 2000). Avastin is a chemotherapy agent that is used to 
block VEGF expression that helps both carcinogenic cells as well as non-cancer cells 
(Blagosklonny 2005). 
Hypoxia and HIF-1 are also implicated in all types of ischemia. During 
atherosclerosis, or hardening of the arteries, a lack of oxygen perfusion results in cardiac 
ischemia, Oxygen and glucose deprivation can result in myocardial infarction. Hypoxia 
induces HIF- l . Increased VEGF expression leads to local angiogenesis and increased 
oxygen perfusion. This decreases incidence and severity of heart attacks (Habib et al. 1991, 
Sabia et al. 1992, Banal et al. 1994). During cerebral ischemia, the induction of certain 
glycolytic enzymes downstream of HiF-1 can increase anaerobic metabolism, and this 
contributes to the protection of neurons in the prenumbra of the brain. (Iyer, et al, 1998). 
Since HIF-1 plays such a critical role in the transcriptional response to hypoxia, drug 
development with it as a target is currently in progress (Giaccia et al. 2003). 
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Discovery of HIF-1, the global regulator of oxygen response 
One of the first molecules to be identified as having a role in hypoxia was the 
erythropoieitc factor EPO, which was induced by hypoxia in liver cell lines (Goldberg et al. 
1988). HIF-1 was first discovered in mammals as a nuclear protein that was able to bind to 
the hypoxia-inducible enhancer in the 3' flanking region of the erythropoietin gene in Hep3B 
cells under the influence of hypoxia or cobalt chloride treatment (Semenza and Wang 1992). 
Later, HIF-1 was shown to be part of a heterodimeric complex consisting of a 120 kDa HIF-1 
alpha and smaller 91-94 kDa HIF-1 beta subunits. (Wang and Semenza 1995). Both subunits 
shaxe two important structural characteristics: the presence of basic helix-loop-helix (bHLH) 
and Per/ARNT/Sim (PAS) domains. The basic domain associates with DNA in a sequence- 
specific manner, and the HLH domain and amino terminal half of the PAS are needed for the 
formation of the HIF-1 alpha/ HIF-1 beta heterodimer (Jiang et al. 1996). HIF-1 beta is also 
termed ARNT (aryl hydrocarbon receptor nuclear translocator), and it can dimerize with 
other transcription factors, while HIF-1 alpha appears to be involved only in hypoxia 
response (Jiang et al. 1996, Ryan et al. 1998, and Iyer et al. 1998b). Researchers have 
isolated 3 HIF-alpha genes (HIF-1 alpha, HIF-2 alpha, and HIF-3 alpha) that show differing 
expression patterns in different types of tissues and cells (Tian et al. 1997). 
The hypoxia response element is the sequence present in promoters or enhancers of 
HIF-1 target genes that allows for DNA binding and the upregulation of transcription of these 
genes. Other coactivators and post-translational modifications contribute to HIF-1 
transcription activity. (Jiang et a1. 1996 and Carrero et al. 2000). Known coactivators such as
p300/CBP are needed for higher transcriptional function of HIF (Dames et al. 2002). HIF-1 
alpha contains two transactivation domains that are responsible for recruiting and interacting 
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with coactivators. These domains are also important because of the posttranslational 
modifications that take place in these regions (Huang et al. 1996, Richard et al. 1999, Bruick 
and McKnight 2001, and Jeong et al. 2002). An oxygen-dependent degradation domain 
located on HIF-1 alpha allows for oxygen concentration to control the stability of HIF-1 
alpha, which will be described later (Huang et al. 1998). 
HIF-1 actions during hypoxic conditions in mammals 
During hypoxic conditions, HIF-1 alpha translocates to the nucleus because of two 
nuclear translocation signals (Kallio et al. 1998). This event occurs independent of HIF-1 
beta/ARNT because HIF-1 beta has been observed to be a nuclear protein already and that 
translocation still occurs in HIF-1 beta mutants (Chilov et al. 1999). This translocation 
occurs rather quickly, as HIF-1 alpha protein has been shown to accumulate in the nucleus 
within 2 minutes after the exposure to hypoxic conditions. (Jewell et al. 2001). Conversely, 
exposing hypoxic-treated animals to increasing amounts of oxygen reduced this translocation 
and binding within 4-8 minutes, and nuclear HIF is not easily detected in oxygen-rich 
conditions because HIF-1 alpha is quickly degraded. (Jewell et al. 2001). Thus, it was 
discovered that the transcription of downstream genes depends on both the amount of HIF-1 
alpha that is allowed to translocate to the nucleus and the amount of DNA binding that takes 
place in the nucleus. (Jiang et al. 1996). 
Qxygen-regulated HIF-1 degradation and action 
In experiments done by the Ratcliffe, Kaelin, and McKnight labs, it was discovered 
that HIF-1 alpha is enzymatically altered in an oxygen-dependent manner. {Ivan et al. 2001 
and Jaakola et al. 2001). Enzymes were found to hydroxylate two proline residues by 
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recognizing a LXXLAP motif in the oxygen-dependent region of the three HIF alphas in 
mammals. (Jaakola et al. 2001 and Ivan et al. 2001). Later, a conserved family of prolyl-4- 
hydroxylases was found to be responsible for this posttranslational modification (Bruick and 
McKnight 2001). Also at this time, a homolog, EGL-9, was biochemically identified as 
regulating a HIF-lalpha homolog in C. elegans (Epstein et al. 2001). This reaction requires 
oxygen as a primary substrate, as well as 2-oxoglutarate, iron, and ascorbate. Inhibition of 
this reaction using other iron chelators and cobalt confirm the role of PHDs as important 
molecules in the known oxygen-sensing pathway (Epstein et al. 2001). 
VHL, the von Hippel Lindau tumor suppressor protein, targets hydroxylated HIF 
alpha for proteasomal degradation (Ivan et al. 2001 and Jaakola et al. 2001). VHL comprises 
part of a E3 ubiquitin-ligase complex that targets proteins to the proteasome for degradation. 
(Maxwell et al. 1999 and Krek 2000). Pharmacological or genetic inhibition of VHL 
transcription leads to an increase in the stabilization and accumulation of HIF-1 alpha, thus 
contributing to the evidence of a pathway that can effectively degrade hydroxylated HIF-1 
alpha (Maxwell et al. 1999). 
Regulation of response to hypoxic conditions—Homologous mechanisms in both 
mammals and C. elegans 
Homologous genes in this pathway exist in C. elegans. The homologs of HIF-1 alpha 
and HIF-1 beta are hif-1 and aha-1 (Powell-Coffman et al. 1998 and Jiang et al. 2001). 
Mutant C. elegans lacking a functional copy of hif-1 are relatively healthy if cultured in 
normal lab conditions, but they show a high level of lethality when cultured in hypoxic 
conditions (0.5%-1.0% oxygen in C. elegans) (Jiang et al. 2001 and Padilla et a1. 2002). 
Epstein et al. employed genetic approaches in C. elegans to identify the prolyl hydxoxylase 
that modified HIF-1 alpha in an oxygen-dependent manner. Candidate genes in the 2- 
oxoglutarate-dependent-oxygenase family were searched to determine which genes would 
increase HIF-1 levels when mutated. The identification of egl-9, a prolyl hydroxylase that 
resulted in an egg-laying defect phenotype, completed the pathway by which HIF-1 is 
recognized by VHL (Trent et al. 1983 and Epstein et al. 2001). There appears to be only one 
prolyl hydroxylase in C. elegans, as there is a complete loss of HIF-1 regulation in the 
absence of a functional egl-9 gene (Epstein et al. 2001). Researchers have also identified 
three prolyl hydroxylases in mammals, called PHDs (Bruick and McKnight 2001, Epstein et 
al. 2001 and Ivan et al. 2002). The basic mechanism of HIF-1 protein level control by EGL- 
9 and VHL-1 is evolutionarily conserved, and the ease of using C. elegans as a model system 
make its study viable in this pathway (Figure 1). 
Additional HIF-1 regulatory pathways 
While the basic mechanism for HIF-1 degradation is known, there are many other 
pathways and molecules involved in this complex process that are just beginning to be 
deciphered. The Ratcliffe Lab found that compared to vhl-1 mutants, egl-9 mutants 
expressed HIF-1 target genes at a higher Level {Bishop et a1.2004). Also, vhl-.1 mutants do 
not have a severe egg-laying phenotype or increased sensitivity to cyanide like egl-9 mutants 
have (Gallagher and Manoil 2001). Both of these results suggest that EGL-9 has functions 
independent of VHL-1, and that these functions do not require VHL- ~ or EGL-9 enzymatic 
activity. 
In addition to the proline residues that are hydroxylated during normoxia, a third 
asparagyl residue is hydroxylated on HIF-1 alpha when oxygen levels are high enough. This 
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hydroxylation inhibits binding of HIF-1 alpha to the coactivator CBP/p300. If CBP/p300 
cannot be recruited, HIF-1 alpha cannot be activated and transcription of downstream genes 
cannot take place. This asparagyl hydroxylase is commonly referred to as FIH-1 (Factor 
Inhibiting HIF) (Lando et al. 2002 and Freedman et al. 2002). Findings suggest that 
interaction of CBP and p300 is essential for neaxly all HIF-responsive transcription, but there 
are coactivators limited to cell-specific types (Kasper et al. 2005 and Gray et al. 2005). It has 
also been shown that the acetyltransferase ARD 1 acetylates a lysine group within the 
oxygen-dependent domain of HIF-lalpha, which inhibits its transcriptional activation and 
protein stability, thus stimulating its degradation. This acetylation increases the interaction 
of HIF-lalpha with pVHL, which targets degradation (Jeong, 2002). 
Outstanding questions regarding regulation of HIF-1 
It is clear that HIF-1 is regulated on a variety of levels. Are there additional pathways 
that have yet to be discovered`? Do the pathways act only on HIF- l , or do they work to 
regulate HIF-1 through other molecules? Are there known regulators of HIF-1 (such as 
VHL-1) that act in other ways on the regulation of HIF-1 ? Data presented above suggests a 
more complicated network involving EGL-9 and VHL- l . Therefore, the study of the 
attenuation of HIF-1 activity deserves attention. 
C. elegans, a model organism 
Caeno~habditis elegans is a soil nematode indigenous to most parts of the world. 
Sydney Brenner first proposed it as a model organism in the early 1960s. He thought it 
would be a good organism by which to elucidate areas in the nervous system and 
development. Worms can be easily grown on agar plates containing the E. col i strain OP 5 0 
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as food, and can also be grown in liquid culture. They are stored at temperatures usually 
ranging from 1 S degrees Celsius to 25 degrees Celsius. There are two sexes in C. elegans: 
males and hermaphrodites. Adults are about 1 mm long and can be observed under a 
dissecting microscope. Hermaphrodites can reproduce by self-fertilization, as they produce 
both sperm and eggs. Self-progeny that is produced is usually also hermaphroditic in sex. 
Hermaphrodites have 2 X chromosomes, and spontaneous XO males arise from X-
chromosomal nondisjuction at a rate of 1 in 500. Males can fertilize hermaphrodites to create 
cross-progeny, of which the resulting offspring are approximately 50% hermaphroditic and 
50% male (Wood 1998). 
C. elegans progeny go through a life cycle lasting about 3 days under good 
conditions, and lifespan is 3 weeks. A hatched larvae goes undergoes four larval stages 
(called Ll, L2, L3, and L4 respectively), before emerging from the fourth molt as a 
reproductively able adult. (Wood 1998) 
In addition to these physical characteristics, C. elegans possesses many other qualities 
that make it suitable for study. Electron microscopes have been used to elucidate the 
complete anatomy (White et al. 1976), and the characteristics and locations of all somatic 
cells are also known. Developmentally, the entire cell lineage is known, as well as cell 
division information such as where and when each cell divides, and from which cell it arises 
(Sulston and. Horvitz 1977; Sulston et al. 1983; Kimble et al. 1978). 
C. elegans is also a very simple organism and amenable to genetic studies. The 
haploid genome is 1 OOx 106 nucleotide pairs, arranged on six chromosomes (five autosomes 
and one sex chromosome) (Wood et al. 1998). Mutations can be induced at high frequencies 
in C. elegans using a variety of mutagens, including ethylmethanesulfonate (EMS). Keeping 
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mutant strains is relatively easy because C. elegans can be frozen in liquid nitrogen and 
thawed for use at a later date (Wood 1998). 
The C. elegans genome was sequencing project was completed in 2002. The 97- 
megabase sequence predicts approximately 19,000 genes, of which function is still being 
determined. (C. elegans sequence consortium). There are approximately 110 confirmed 
microRNA genes also (Grad et al. 2003). WormBase is an excellent source of biological data 
on C. elegans and related nematodes that allows researchers to study individual genes, DNA 
sequences, and literature citations. WormBase is a dynamic resource that constantly changes 
according to new findings in the field (O' Conne112005). 
RNA interference usage in C. elegans 
One of the resources fueling findings in C. elegans is the use of double-stranded RNA 
interference (RNAi) in both large and small-scale experiments. RNA-mediated interference 
was first described in C. elegans as a way to potently degrade gene-specific mRNA by 
introducing double-stranded RNA of that particular gene (Fire et al. 1998 and Bass 2000). 
The technique of RNAi produces gene-specific loss-of-function or hypomorphic phenotypes 
while also showing interference in progeny. RNAi is effective and easy to perform in C. 
elegans, and therefore, is a very popular reverse-genetics tool that is helping to determine the 
functions of many genes. The first published experiments using RNAi involved the 
microinj ection of dsRNA into the gonad of hermaphrodites (Fire et al. 1998). However, 
RNA can be absorbed through the gut and delivered to somatic tissues and the germ line, so 
soaking worms in buffer containing dsRNA and feeding worms with a bacteria that express a 
target gene dsRNA have become viable options as well (Tabara et al. 1998 and Timmons and 
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Fire 1998). The feeding method of RNAi employs an L4440 double-T7 promoter vector that 
is transformed into a bacterial strain carrying IPTG-inducible expression of T7 polymerase 
(Timmons and Fire 1998). Data from large-scale RNAi screen have shown that RNAi is 
more effective for analyzing genes that cause early lethality than for analyzing genes 
involved in post-embryonic development (Kamath and Ahringer 2003). In addition, it was 
found that genes involved in neuronal function axe not as susceptible to RNAi when 
compared to other cell types (Timmons et al. 2001). Researchers later found that C. elegans 
lacking the RNA-directed RNA polymerase (rrf-3 gene) were more susceptible to RNAi. 
This is because dsRNA is cleaved into small 20 nucleotide fragments that can serve as 
primers to initiate RNA-directed RNA polymerase that can amplify interference (Zamore et 
al. 2000 and Lipardi et al. 2001). 
THESIS ORGANIZATION 
The overarching goal of my research is to identify and characterize potential negative 
regulators of HIF-1 in C. elegans. 
Chapter 1 is the literature review. First, I explain the importance of oxygen tensions 
in cells and the medical implications of hypoxia. Then, the master regulator of hypoxia 
(HIF-1) is described in detail, followed by the basic pathway known to regulate HIF- l . I 
describe how this basic pathway is evolutionarily conserved in C. elegans. Some of the 
secondary pathways affecting HIF-1 expression are then touched upon. Finally, I explain the 
usage of C. elegans as a model system and the advantages it has in performing RNAi 
experiments. 
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In chapter 2, I describe the efforts that have been made to screen for genes that 
negatively regulate HIF-l. Also, I explain the efforts I have made to map the shy-3(ia30) 
(regulator of hypoxia) gene in order to preliminarily characterize it. Chapter 3 includes the 
use of RNAi to test the hypothesis that two genes, chn-1 and ufd-2, are involved in a novel 











Figure 1. The basic mechanism of HIF-1 degradation is evolutionarily conserved. A. 
Schematic diagram showing the degradation process in C. elegans: HIF-1 is hydroxylated by 
EGL-9, then the hydroxylated HIF-1 is recognized by VHL-1 for proteasomal degradation. 
B. The homologous proteins in both types of organisms and respective names. 
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Preliminary characterization of the shy-3 gene 
ABSTRACT 
HIF-1 (hypoxia inducible factor) is a heterodimeric transcription complex responsible 
for the regulation of several cellular and systemic responses to low oxygen in mammals. 
During periods of normal oxygen levels, HIF-1 alpha is hydroxylated by a prolyl hydroxylase 
and is mediated for proteolytic degradation by the von Hippel Lindau (VHL) tumor 
suppressor. This pathway is evolutionarily conserved in C. elegans, with hif 1, vhl-1, and 
egl-9 encoding the homologs of HIF-1 alpha, VHL, and PHD, respectively. Using classical 
genetic techniques, I have made progress in identifying and characterizing the shy-3 gene, 
which when mutated, results in the increased expression of a positive reporter for HIF-1 
activity. Current data shows that the shy-3 gene falls between 2.66 and 2.84 on chromosome 
I of the C. elegans genome. 
INTRODUCTION 
Hypoxia is the condition in which cellular oxygen levels are insufficient to meet the 
physiological demands for oxygen. HIF-1 serves as a critical regulator in mammalian 
response to hypoxia, and is composed of two subunits: an alpha subunit and a beta subunit. 
Both of the HIF-1 subunits are part of the basic helix-loop-helix PAS family of transcription 
factors (Jiang et al. 1996). HIF-1 beta is constitutively expressed, while HIF-1 alpha is 
stabilized in response to hypoxia. During periods of high oxygen levels, HIF-1 alpha binds 
to the von Hippel-Lindau tumor suppressor protein (VHL), where HIF-1 alpha is targeted for 
proteasomal degradation. It was later discovered that HIF-1 alpha contained an oxygen-
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dependent domain (ODD) that could be enzymatically modified to allow for VHL-mediated 
degradation (Jaakola et al. 2001 and Ivan et al. 2001). Homologs of HIF-1 alpha, HIF-1 beta, 
and VHL have been identified in C. elegans, and are termed hif=1, aha-1, and vhl-1 (Jiang et 
al. 2001 and Epstein et al. 2001). 
Genetic approaches were used in C. elegans to identify the modifying enzyme in this 
pathway, which was termed egl-9. EGL-9 hydroxylates specific proline residues in the 
conserved LXXLAP motif in the ODD region of HIF-1 (Epstein et al. 2001). This 
hydroxylation increases HIF-1's affinity for VHL- l , and its subsequent degradation. 
Homologs of EGL-9 have been found in mammals, called PHDs (Bruick and McKnight 
2001, Epstein et al. 2001, and Ivan et al. 2001). 
In addition to this pathway, there have been many molecules identified as playing a 
role in the regulation of HIF-1 alpha activity. Post-translational modifications of HIF-1 alpha 
include phosphorylation, acetylation, and other methods of hydroxylation (Jeong et al. 2002, 
Lando et al. 2002, Freedman et al. 2002). HIF-1 alpha's transcriptional activity may be 
modulated by growth factor stimulation via small GTPases and mitogen-activated protein 
l~inase cascades (Semenza 2002 and Hopfl et al. 2004). Are there additional molecules and 
regulators of HIF activity not yet discovered? EGL-9 has been shown to have functions 
independent of VHL-1 in C. elegans (Bishop et al. 2004 and Gallagher and Manoil 2001). 
Also, data suggests that EGLN 1 can inhibit HIF-1 transcriptional activity in a manner not 
requiring VHL (To and Huang, 2005). Therefore, there is promise in studying the ways in 
which HIF activity is negatively regulated. In order to determine additional regulators of 
HIF, we have devised a novel visual assay for HIF-1 function in C. elegans. Using this assay 
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and subsequent mapping efforts, I have made progress in identifying genes involved in 
hypoxia response in C. elegans. 
MATERIALS AND METHODS 
Screening for mutations that misregulate targets of HIF-1 
ZG 119: ials07; vhl-1(okl bl) L4 hermaphrodite worms were washed off 60mm agar-
containing plates with cold M9 buffer and incubated for 4 hours in 50 mM EMS. Worms 
were then washed two times with M9 and approximately 20 worms were placed on each of at 
least 5 new 60 mm OP50-containing agar plates. The mutagenized parental generation was 
allowed to lay approximately 100 eggs, and then they were removed from the plates. After 
approximately 3 days, worms in the F2 generation were assayed for GFP phenotype. Worms 
showing phenotypes different than the parental strain were placed on new 60 mm plates for 
further study. 
Snip-SNP mapping 
A variation of bulked segregant analysis was used (BSA) T11e strain containing ~hy-
3 was crossed into the CB4856 background to create "bulked lysate 1" and was also crossed 
into the N2 background to create "bulked lysate 2". Snip-SNPs were selected from the two 
arms and center of each chromosome: 










































































Fragments were amplified using these confirmed primers for each bulked iysate and 
digested with the corresponding restriction enzyme. The product was subjected to 
electrophoresis on a polyacrylamide gel. 
These gel images were scanned into the image) computer program, and bands were 
quantified in order to determine the relative amount of CB4856 to N2 markers for each allele. 
Then, a measure of linkage for the mutation to the alleles was determined as a unitless map 
ratio of Rm/Rw where: 
Rw=Dw[CB4856]/Dw[N2] Rw corresponds to lanes of bulked lysate 2 (BL2) 
And 
27 
Rm=Dm[CB4856]/Dm[N2] Rm corresponds to lanes of bulked lysate 1 (BL1) 
Dw[CB4856]=density of the CB4856 form of the biallelic marker in BL2 
Dw[N2]=density of the N2 form of the biallelic marker in BL2 
Dm[CB4856]=density of the CB4856 form of the biallelic marker in BLl 
Dm[N2]=density of the N2 form of the biallelic marker in BL1 
A map ratio of 1 (Rm/Rw) indicates that the relative amounts of a biallelic marker in 
each bulked segregate was equal. Conversely, a map ratio that is significantly below 1 
suggests that either the N2 form of an allele predominates in the (mut-) lysate, the CB4856 
allele predominates in the (mut+) lysate, or a combination of both. This internal control 
provides a way to bypass incomplete restriction digestion or a lack of PCR efficiency. Using 
the equation, unlinked maxkers have a map ratio of close to 1, while map ratios close to 0 
suggest that the mutation is linked to a particular snip-SNP. 
Deletion mapping 
5 male shy-3(ia30), ials07, vhl-1(ok161) worms were crossed to 3 hermaphroditic 
SP 1540 mnDfl 11/unc-13;1in-11, a rearrangement strain with a deletion in the 2.23-3.85 
region of LGI. The worms were mated at 20°C on standard OP50-containing plates and the 
F 1 generation was assayed for GFP expression and complementation. 
Three-point mapping 
5 male shy-3(ia30), ials07, vhl-1(ok161) worms were crossed to 3 hermaphrodite unc- 
13(e1091) lin-I1(n56~, ials07, vhl-1(ok161) worms. The worms were mated at 20°C on 
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standard OP50-containing plates. F 1 cross-progeny were picked to new plates and allowed to 
produce self-progeny. The F2 generation was checked for crossover events that lost either 
the uncoordinated or lineage mutation. These worms were picked to new plates and allowed 
to produce self-progeny. The frequency of increased GFP expression in the F3 generation 
can then be assayed to determine the position of the shy-3 gene. 
RESULTS 
Screen design 
A fusion between green fluorescent protein (GFP; Chalfie et al. 1994) and a HIF-1 
target gene was constructed as a visual assay for changes in HIF-1 levels. The nhr-57 gene is 
upregulated by hypoxia, in a HIF-1-dependent manner (Shen et al. 2005). The GFP in the 
reporter construct allows for the identification of mutations affecting the HIF-1 pathway. 
vhl-1 deficient worms carrying an integrated copy of this reporter construct (ials07) express 
GFP in the intestine. This strain was exposed to ethyl methane sulphonate (EMS) (Jorgensen 
and Mango, 2002). This formed the basis for a simple F2 screen, and animals with 
dramatically lower or higher GFP expression were isolated for further study (Figure 1). 
These mutations were termed "rhy" (regulators of the hypoxia-inducible factor). Others in 
the lab, including Chuan Shen, Kelly Gillette, and Abhijeet Shah isolated ten mutations were 
isolated that increased expression of the ials07-GFP reporter (Table 1). Using snip-SNP 
mapping and 3-point mapping, I was able to map the rhy-3(ia30) mutation to a small region 
on chromosome I. 
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Snip-SNP mapping 
Snip-SNP mapping uses single nucleotide polymorphisms between the Hawaiian 
(CB4856) and Bristol (N2) strains of C. elegans. CB485b has 6,222 polymorphisms over 5.4 
Mbp of aligned sequences, and 3,457 of these polymorphisms alters a restriction enzyme 
recognition site, thus giving the term, "snip-SNP". These changes are detectable as RFLPs 
(restriction fragment length polymorphisms) (Wicks et al. 2001). Verified snip-SNPs have 
been catalogued, and the information is available for use on Washington University's 
database (snp.~~~~~;~s~:1.ed~;~1s~.~I~:~~~a~e-anc~.- .ata~ ases-snps.~.:~~i). The proximity of a linked 
marker to the mutation is estimated by the relative proportion of each form of the biallelic 
marker in populations of wild type and mutant genomes. The closer a map ratio is to 0, the 
more likely the gene of interest is linked to that particular marker. Our data shows that ~hy-
3(ia30) maps to the middle of LGI (Figure 2). 
Deletion Mapping 
The use of three-point mapping with phenotypic markers and deletion mapping 
provided 
a more defined map position. The deletion strain SP 1540: nu1Df111 ; ials07; vhl-1 
unc-13; l in-11 ials07 vhl-1 
failed to complement shy-3(ia30); ials07; vhl-1(ok161).
shy-3(ia30) ials07 vhl-1(ok161) 
This suggests that shy-3(ia30) was located within the region between 2.23 and 3.85 on LG I. 
There are approximately 100 defined genes within this region (Figure 3). 
Three-point mapping 
Recombination mapping allowed for further elucidation of the map position of ~hy- 
3(ia30). 32 crossover events were scored in a series of three separate recombination 
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experiments. This led to a map position of 2.75+/-0.09 m.u. on LG I for the relative position 
of rhy-3(ia30) (Table 2). 
DISCUSSION 
Effectiveness of mapping strategies 
Snip-SNP mapping is a very convenient way to assign genes to a linkage group in C. 
elegans. The Washington University database listing polymorphisms between the NZ and 
CB4856 strains contains primer sets that can be used to amplify regions and the 
corresponding restriction enzymes. Not ali of the SNPs have been experimentally confirmed, 
but those that have are indicated on the website. However, there have been reports of 
verified SNP information not working, and adjusting of PCR and restriction digest conditions 
is necessary (Swan et al. 2002). We found that SNPs reported in a paper by Wicks et al. 
2001 work well for the rough. approximation of map position in a high throughput system. 
After attempting to use other reported SNPs on LG I to assign shy-3(ia30) to a more defined 
position, I determined that it would be easier to use other more classical methods to refine 
my search. 
Deletions can be informative in mapping genes, but failure to complement does not 
always indicate that your gene of interest falls under the deletion. In some rare cases, 
extragenic noncomplemenation can occurs, which usually means that the protein produced by 
the gene of interest forms a common assembly factor with a protein produced by one of the 
genes missing in the deletion region. Also, deletions can sometimes be limited to certain 
points in the genome, and the endpoints of deletions are not always well defined. 
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Three-point mapping with phenotypic markers is easy to perform and serves as a 
time-tested way to reliably map genes to a defined genetic interval. But, three-point mapping 
can be a tedious process if the phenotypic markers are difficult to identify, there are few 
recombination events, or if the mating efficiency of males is low. The basic premise of 
three-point mapping depends upon a large number of crossover progeny, with each event 
narrowing the margin of error for your gene of interest's map position. 
Criteria for promising candidate genes in the region where rhy-3 maps 
T11e pathways involving HIF-1 are beginning to be elucidated, and there are a few 
areas that seem to be involved in HIF-1 and hypoxia response in C. elegans. A senior 
graduate student in our Iab found that 63 genes were regulated by hypoxia in a hif-1 
dependent manner by microarray analyses. Metabolic enzymes, signaling molecules, and 
extracellular matrix protein mRNA levels were altered, providing evidence that genes in 
these categories could be mutable to an overexpression of HIF-1 tShen et al. 2005j. Other 
pathways in the introduction of this paper describe pathways and conditions that can lead to 
the overexpression of HIF- l . Using this data, three candidate genes located within the 
boundary points of the mapping data seemed like promising genes that could be mutable to 
an overexpression of HIF-l. There are approximately 80 genes in this area, and only 13 have 
defined functions. Three genes stood out as promising candidates in a search of what shy-3 
could encode. 
~`aeno~Izabditis elegans p53 
The p53 tumor suppressor gene is frequently mutated in human cancers and maintains 
genomic stability by regulating cell cycle progression and apoptosis in response to DNA 
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damage (Ko and Prieves 1996). The C. elegans homolog of p53 is cep-1, located at 2.74 of 
LG I. cep-1 is a promising candidate because cep-1 mutants are more susceptible to death 
under 0.5%oxygen (hypoxic) conditions (Derry et al. 2001). This information led me to 
begin sequencing cep-1 to see if there were any obvious mutations in its coding regions that 
could be causing HIF-1 overexpression. 
Mitochondrial link to HIF? 
Two of the defined genes in the shy-3 region, dhs-3 and sod-2, are predicted to be 
mitochondrial in nature. The connection between mitochondria and oxygen sensing is 
currently being debated. Experiments with cell lines lacking mitochondrial DNA showed 
deficient oxygen sensing, and thus the stabilization of HIF alpha (Chandel et al. 1999; 
Chandel et al. 2000; and Schroedl et al. 2002). However, other findings show that regulation 
of HIF-1 does not require a functioning mitochondrial respiratory chain (Vaux et al. 2001 
and Srinivas et al. 2001). The "mitochondrial oxygen-sensing" model says that oxygen 
availability affects mitochondria's ability to produce reactive oxygen species (ROS), which 
somehow signal to HIF. However, reports conflict in this area as well, with most groups 
reporting an increase in ROS species in response to hypoxic conditions, and some reporting a 
decrease in ROS species in response to hypoxic conditions (Chandel et al. 2000 and Fandrey 
et al. 1994). Also, a direct molecular link between ROS and HIF alpha regulation has not 
been found. Although this link is not clear, there is evidence that the prolyl hydroxylases in 
the HIF pathway provide the link between mitochondrial function and HIF alpha regulation. 
Succinate is a product produced from 2-oxogluarate in the hydroxylation of HIF- 
1 alpha by PIED. Succinate is an inhibitor of PHD activity and the Krebs cycle enzymes 
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involved in succinate production are known as tumor supressors. This is consistent with 
findings where an inactivation mutation in these supressors causes constitutive expression of 
HIF alpha in cancer cells (Dalgard et al. 2004 and Selak et el. 2005). Oxygen itself might 
provide the link between PHDs and mitochondria) function. Inhibitors of mitochondria) 
function were suggested to decrease HIF alpha levels by cellular redirection of oxygen from 
mitochondria to the prolyl hydroxylase oxygen sensors (Hagen et al. 2003). The definitive 
link between mitochondria and HIF has not been elucidated, but much evidence points to 
promise in studying this further. 
How to proceed 
In order to fully elucidate the mechanisms by which shy-3 acts in the HIF pathway, it 
will be necessary to perform molecular assays to look at HIF-1 protein levels. I have 
attempted measuring mRNA levels of HIF-1 dov~mstream genes with limited success using 
Northerns, qRT-PCR, and RPAs. It is important to assay other HIF-1 target genes because 
our visual assay detects the expression of a target and not HIF-1 itself. It will also be helpful 
to measure the levels of HIF-1 protein. Hopefully, the data presented above will help 
determine exactly where shy-3 is, and molecular data will provide clues about how this gene 
acts in response to HIF-1 and hypoxia response. 
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self-fertilizing hermaphrodites with weak GFP expression 
1 
F1 generation: mutation ials07 vhl-1(ok161) 
+ ials07 vhl-1(ok16~) 
1 
F2 .generation: mutation ials07 vhl-1(ok161) 
mutation ials07 vhl-1(ok161) 
Figure 1: Screen design and sample picture of screen isolate. Parental strains contain the 
integrated reporter and are deficient in VHL-l. Animals were isolated that overexpress GFP 
(ials07) in both the phary~ and tail. Other animals showed underexpression of GFP (not 
shown). 
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IL IC IR IIL IIC IIR IIIL [1[C I[IR [VL IVC IVR VL VC VR 
752 1357 1644 3557 1423 2765 3853 2053 1342 3545 639 434 694 905 1021 
1971 1128 1537 764 187 914 738 680 398 1706 2116 886 1830 1536 3180 
1448 855 649 2641 1443 1986 555 634 1136 2691 205 5606 209 186 410 
2703 411 141 843 246 427 75 152 507 1165 695 514 579 '1599 2616 











Linkage group designation 
f 
Figure 2: Snip-SNP mapping data shows rhy-3(ia30) is linked to the middle-to right arm of 
LG I. Each linkage group has 3 primer sets/restriction enzymes, labeled at the top of each 
column as L (left), C (center), and R (right). The first two numbers underneath the LG 
designation are amount of signal calculated by image J for each band in the 1St bulked lysate. 
This means that the first number is the density of the CB4856 form of the bialleic marker in 
BLl and the second number is the density of the N2 form of the biallelic marker in BLl. 
3b 
Dividing the first number by the second number gives Rm. The second set of numbers 
corresponds to bulked lysate 2, and Rw values. So, the third number is the density of the 
CB4856 form of the biallelic marker in BL2 and the fourth number is the density of the N2 
form of the biallelic marker. Dividing the third number by the fourth number gives Rw. The 
decimal values in italics represent Rm/Rw, which is a unitless measure of a gene to a marker. 
Numbers closer to 0 usually represent that a gene is linked to that marker, since there is a 
more proportionate amount of density in each lane. This data shows two love points, one at 
IR and another at IVR. Since the two points surrounding IVR don't appear to be linked at 
all, the amount of linkage at this point is suspect. Other mapping data confirm shy-3's 
location near the center of LGI. 
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let-87 (2.24), let-88 (2.28) 
let-90 (2.29), gna-2 (2.31). let-85 (2.29), let-82 (2.29}, let-81 (2.29), gl d-1 (2.29), tag-
173 {2.32) 
adr-1 (2.3 5), doh-3 (2.37), apb-3 (2.3 8), hid-3 (2.3 8) 
unc-55 (2.41), nmy-2 (2.43), bat-1 (2.43), cyc-1 (2.44), ath-1 (2.45}, apr-1 (2.45), the-3 
(2.46), 
let-538 (2.50), let-535 (2.50), Mme-8 (2.51) 
spy-4 (2.54), let-80 (2.56), lin-10 (2.58), mau-2 {2.58) 
unc-109 (2.62) dhs-3* (2.68) 
let-89 (2.70), spe-12 (2.70), k~i-1 {2.70), ceh-1 (2.70), kin-10 (2.71), mei-1 {2.71), abts-
1 {2.71), cep-1 * (2.74), ~sd 6 (2.76), lin-28 (2.79) 
pqn-28 (2.82), sod-2 * (2.83), unc-120 {2.84) 
ceh-6 (2.85), zhp-3 (2.88), gpa-1 S (2.90) 
gon-2 (2.92), daf-8 (2.92), pan-4 (2.93), edc-3 (2.95), fey-6 (2.96), fey-1 (2.96), egl-31 
(2.96), ces-1 (2.96) 
evl-17 (3.00), evl-16 (3.00), evl-9 (3.00), syp-3 (3.01), tlf-1 (3.02), cdk-8(3.02), cle-
f (3.04), imp-1 (3.06), lmn-1 (3.06), mfb-1 {3.09) 
tit-1(3.08), sup-17 (3.10) 




egl-32 (3.40), tsp-1 S (3.40), spd-2 (3.40}, tag-214 (3.41), tax-2 (3.41) 
acs-19 (3.43), tag-157 (3.46) 
gad-54 (3.51) 
mef-2 (3.56} 
mel-26 {3.61), adn-1 (3.61), dyf-S (3.63), tag-1 S (3.63) 
tag-255 (3.65), aph-1 (3.67) 
tat-S (3.71), this-1 (3.73), lin-41 (3.76), pab-3 {3.76), met-8 (3.76), nob-3 (3.76), min-2 
{3.76), stn-1 (3.77), stl-1 (3.77), smn-1 (3.78) 
klp-16 (3.78), tag-328 (3.78),i~x-1 (3.79), ah~-1 * (3.79), lin-53 (3.80}, hsY-9 (3.82), dhs-
4 (3.82}, npp-14 (3.84), cel-1 (3.85), ikb-1 (3.85), ~p1-14 (3.85), oc~l-1 (3.86) 
Figure 3: A graphic of the defined genes contained within the region of 2.23 and 3.85 of LG 
I, which is deleted in SP1540. All genes are labeled with known map position and genes of 
interest in hypoxia response are marked with an *. Complementation tests using this strain 








Number of each type of crossover 
event 
Unc non Lin, 
elevated GFP levels 
unc-13, shy-3, + 
_ 
S 
unc-13, shy-3, linll 
Lin non Unc, 
regular GFP levels 
+, +, lin-11 3 
unc-13, shy-3, lin-11 
Unc non Lin; 
regular GFP levels 
unc-13, +, + 3 
. unc-13, shy-3, lin-11 
Lin non Unc, 
elevated GFP levels 
+, shy-3, lin-11 21 
unc-13, shy-3, lin-11 
Table 2: Recombinant chromosomes isolated from unc-13(e1091, lin-11(n566) and rhy- 
3(ia30). The first 2 categories represent crossover events that occurred between rhy-3(ia30) 
and the unc-13 phenotypic marker at 2.07 m.u. The second 2 categories represent crossover 
events that occurred between rhy-3(ia30) and the lin-11 phenotypic marker at 4.81 m.u.. 
These results indicate that rhy-3(ia30) is closer to unc-13. Each event is worth .0856 map 
units, so the approximate position of Nhy-3(ia30) is 2.75+/- 0.09 m.u. on LG I. 
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CHAPTER 3 
Testing the hypothesis that chn-1 and ufd-2 play a novel role in v/il-l-independent 
degradation of HIF-1 in C. elegans 
ABSTRACT 
HIF-1 is the master regulator of oxygen homeostasis. Under conditions where 
oxygen is abundant, HIF-1 is hydroxylated by EGL-9 prolyl hydroxylase, and the 
hydroxylated HIF-1 is recognized by VHL- l , which leads to proteasomal degradation of 
HIF- l . LJFD-2 and CHN-1 are important for degradation of stress-induced proteins in a 
variety of organisms, but it is not known if either acts in a pathway to degrade proteins 
related to HIF-1 and hypoxic stress. Other studies have revealed that cells utilize multiple 
strategies to attenuate HIF-1 function. Here, I test the hypothesis that HIF-1 is regulated by 
UFD-2 and CHN- l . Using a feeding RNAi study, I assessed whether or not the introduction 
of chn-1 and ufd-2 dsRNA would act to elevate HIF-1 levels in strains both with and without 
vhl-1 and in strains more susceptible to RNAi effect. Results show that RNAi inactivation 
of both genes does not produce increased HIF-1 expression at 20°C or 25°C as measured by 
a reporter in which GFP is fused to a promoter of a HIF-1 downstream gene. 
INTRODUCTION 
In mammals, the hypoxia-inducible factor 1 (HIF-1) functions as a master regulator 
of oxygen homeostasis by activating gene expression in response to low oxygen conditions 
(Giaccia et ~al. 2003; Kaelin et ai. 2002; Pugh and Ratcliffe, 2002). Proteins encoded 
downstream of HIF-1 include vascular endothelial growth factor, erythropoietin, and insulin-
like growth factor 2 that help the cell survive in compromised oxygen levels. Currently, 
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many studies are underway to elucidate the mechanisms by which HIF-1 mediates changes in 
these types of genes in response to changing oxygen concentrations. 
HIF-1 contains an oxygen-dependent alpha subunit and constitutively expressed beta 
subunit (Wang et al. 1995). Both subunits contain a basic helix-loop-helix (bHLH) and PAS 
domain that help bind DNA and mediate heterodimerization (Jiang et al. 1996). The alpha 
subunit has an oxygen-dependent domain (ODD) that mediates protein stability due to 
oxygen concentration (Huang et al. 1998). During normoxic conditions, HIF-1 alpha is 
ubiquitinated and undergoes degradation by the 26S proteasome (Huang et al. 1998; Kallio et 
al. 1999; Salceda and Caro 1997). 
This process of degradation requires prolyl hydroxylation and the von Hippel Lindau 
(VHL) protein that binds to the hydroxylated HIF-lalpha. VHL is the recognition 
component of an E3 ubiquitin ligase that functions with E 1 ubiquitin-activating and E2 
ubiquitin-conjugating enzymes to mediate ubiquitination of HIF-1 alpha (Kamura et al. 2000). 
Three prolyl hydroxylases have been identified in mammals that utilize oxygen and 2- 
oxoglutarate to add hydroxyl groups to proline 402 and 564 of HIF-lalpha. These prolyl 
hydroxylases are: EGLN (EGL Nine homolog—originally identified in C. elegans), PHD 
1,2, and 3 (Prolyl Hydroxylase Domain protein), and HPH (HIF-lalpha Prolyl Hydroxylase) 
1, 2, and 3 (Bruicic and McKnight 2001, Epstein et al. 2001, and Ivan et al. 2002). 
While much is known about the degradation of HIF-lalpha by the pathway including 
PHDs and VHL, there are other pathways that and molecules known to control HIF-lalpha 
activity. HIF-lalpha transactivation domain function is regulated by the enzyme FIH-1 
(factor inhibiting HIF-1) that hydroxylates asparagine 803. This blocks the binding of 
coactivators CBP and p300 due to steric hindrance (Lando et al. 2002). Also, FIH-1 can bind 
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VHL and inhibit HIF-1 transcriptional activity (Mahon et al. 2001). Acetylation of lysine 
532 within the oxygen-dependent domain of HIF-lalpha by ARD1 acts in order to inhibit its 
transcriptional activation and protein stability. These reports suggest that acetylation and 
hydroxylation is needed to increase the interaction between VHL and HIF-1 alpha, and 
consequently affects proteasomal degradation (Jeong et al. 2002). Most recently, a protein 
named OS-9 was found to interact with both HIF-lalpha and HIF-lalpha prolyl hydroxylases 
in order to promote proteasomal degradation (Baek et al. 2005). 
C. elegans has proven to be an effective model system to elucidate outstanding 
questions in the hypoxia response pathway. The homolog of HIF-lalpha is hif-1, and the 
pathway containing HIF-1, EGL-9, and VHL is conserved (Epstein et al. 2001, Jiang et al. 
2001). It is known through experiments with C. elegans that egl-9 acts in a pathway 
independent of vhl-1. Egl-9 mutants show both a severe egg-laying defect and a decreased 
sensitivity to cyanide, and vhl-1 mutants show neither of these defects (Trent et al, 1983; 
Gallagher and Manoi12001). In addition, unpublished data from our lab shows that high 
levels of HIF-1 protein can persist in a wild-type vhl-1 background. This data suggested a 
model in which there is another degradation pathway for HIF-1 in C. elegans that utilizes egl- 
9, but is independent of vhl-1. 
CHIP (C-terminus of Hsp70 interacting protein) was first identified in mammals as a 
Tetratricopeptide repeats (TPRs) domain-containing protein shown to modulate chaperone 
activity (Ballinger et al. 1999). Chaperones are known to participate in the folding of new 
proteins, and can also protect proteins during intracellular protein tra~cicing and during 
periods of cellular stress (Hartl 1996, Bukau and Norwich 1998). It is known that several 
neurodegenerative diseases are caused by protein misfolding or improper aggregation (Ross 
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and Pickart, 2004). For example, in Parkinson's disease, parkin cannot fully ubiquitylate the 
Pael receptor without the help of CHIP (Imai et al. 2002). Mice lacking CHIP have 
compromised responses to thermal stress, with 100% dying shortly after thermal challenge 
(Dai et al. 2003). Increase of AtCHIP in ~~abidopsis leads to increased sensitivity to 
temperature stress (Yan et al. 2003). All of these findings suggest that imbalance of CHIP 
expression can lead to serious consequences in stress tolerance. Recently, a homolog of 
CHIP was found in C. elegans, termed ceCHIP, or chn-1 (Khan and Nukina 2004). RNAi 
treatment of C. elegans with ceCHIP leads to various behavioral abnormalities and a possible 
formation of dauers under temperature stress. Since CHIP is known to have ties to stress 
response, it might be involved in a pathway leading to degradation of HIF-1 independent of 
vI-~L-1. 
Sometimes, proteins need to have multiubiquitin chains in order to be degraded at the 
proteasome. The process of ubiquitination is a we11-defined process that is catalyzed by a 
series of enzymes. E 1 (ubiquitin-activating enzyme) hydrolyzes ATP to form ahigh-energy 
thioester between a cysteine of its active site and the C terminus of ubiquitin. This activated 
ubiquitin is then passed to E2s (ubiquitin-conjugating enzymes), which form thioester-linked 
complexes with ubiquitin. Then, ubiquitin is covalently attached to the substrate protein 
directly by the E2s or by E3 s (ubiquitin-protein ligases). A newer ubiquitination factor is E4, 
which acts with the other ubiquitination enzymes to build long chains of ubiquitin onto a 
given substrate (Koegl et al. 1999). one of the members of this group includes the yeast 
protein UFD2, which is involved in. stress tolerance. Mutants show hypersensitivity to 
elevated temperatures, cadmium, ethanol, and fluoro-phenylalanine (Koegl et al. 1999). 
UFD2 is a highly conserved protein, showing homoiogs in humans, Dictyostel ium, 
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S'chizosaccha~omyces pombe, and C. elegans. Since UFD2 is thought to play an important 
role in the degradation of stress-induced aberrant proteins, it was also a good candidate to act 
in a degradation pathway with HIF- l . We concentrated on these two genes because they 
were both located in the region of where genes front our forward genetic screen (described in 
chapter 2) tentatively mapped. 
To address whether either of these genes is involved in a degradation pathway for 
HIF-1 independent of VHL- l , I used RNA-mediated interference to inactivate chn-I and ufd-
2. The tests were conducted in strains carrying GFP fused to a promoter of a HIF-1 target 
gene, which proved to be a reliable indicator of HIF-1 levels. 
MATERIALS AND METHODS 
Snip-SNP mapping 
Protocols were used as described in chapter 2. We mapped two genes from the 
genetic screen: 1. shy-3(ia31); ials07; vhl-1(ok161) 2. rhy-5(ia32); ials07; vhl-1(ok161) using 
primers listed in chapter 2. 
Worm strains used for RNAi 
Worm strains used in this experiment are described below: 
ZG 120: ials07; vhl-1(ok161) 
ZG123: ials07 
ZG242: ials07; vhl-1(ok161); YYf-3(pk142c~ 
All strains were grown under standard published conditions on plates containing the 
E. coli bacteria OP50 as a food source (Wood et al. 1998). 
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Clones 
Fragments for RNAi were obtained from PCR (polymerase chain reaction) of coding 
DNA or from existing vectors containing genes of interest. Fragments were cloned into the 
L4440 feeding vector (pPD129.46) and checked by restriction digest for correct composition. 
Plasmids were transformed into HT115(DE3) Rnase III-deficient E. coli with IPTG-inducible 
T7 polymerase activity (F-, mcrA, mcrB, IN(rrnD-rrnE)l, lamda-, rnc14::Tn10(DE3 
lysogen:lacLTVS promoter-T7 polymerase)) (Kamath et al. 2000). Six total constructs were 
made utilizing the L4440 vector in HTl 15(DE3) cells: Empty vector containing no test 
genes, hif-1 as a positive control for minimal GFP expression, shy-1 as a positive control for 
increased GFP expression, and the test genes chn-1, ufd-2a, and ufd-2b. 
The following primer pairs were used for the 2 fragments of ufd-2: 
ufd-2(a)F: 5' GTGAATTCCAGGCAGATGTTGAAAGCAA 3' 
R: 5' GTGAATTCGAGTGCGAATGTCATTGGTG 3' 
ufd-2(b)F: 5' GAGAATTCGCACAGAGGCTCGTTATTCC 3' 
R: 5' GAGAATTCGCAACGATACAAACTCCCGT 3' 
All other clones used for RNAi purposes (constructs containing chn-1, hif-1, and rhy- 




Single colonies of HTl 15 (DE3) containing cloned L4440 plasmids were picked and 
grown in 5 mL LB with 50 µg/ml ampicillin for 7.5 hours. 100 µl of each of these cultures 
were seeded on 60mm standard NGM agar with 25 µg/mL carbenicillin and 1 mM IPTG. 
Plates were left at 25°C overnight to dry and to induce transcription. 
RNAi by feeding 
2 L4 stage hermaphrodite worms were washed with M9 buffer and placed on each 
NGM plate containing the seeded bacteria expressing dsRNA for each gene and were then 
incubated for approximately 30 hours at 25°C or 40 hours at 20°C to allow the RNAi to take 
effect. These adults were replica plated onto another plate that was seeded in the same 
manner with the same bacteria. After 24 hours, the adults were removed from the second 
plate and all progeny were scored for levels of GFP expression when at the L4 stage under a 
LTV light microscope. 
RESULTS 
Mapping data 
As described in Chapter 2, our lab had isolated several mutations that resulted in 
over-expression of a HIF-1 target gene. Two of these mutations mapped to areas of interest 
in the genome. The mapping data for rhy-3(ia30) showed that was on the middle-right arm 
of LG I and shy-S(ia32) is in the middle of LG II. However, the mapping resolution was low 
due to the usage of only 3 markers we used for each linkage group, so the area that could 
contain each of these genes was quite large. ufd-2 is at 0.67 map units on chromosome II 
(LG II), and chn-1 is at 0.82 on LG I. cdc-48 is involved in a pathway with ufd-2, but I did 
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not test it in RNAi studies because the RNAi phenotype is larval lethal (Figuxe 1). The 
combination of map position and involvement of both these genes in proteasomal 
degradation in stress response made them viable candidates for testing as genes involved in a 
novel HIF-1 regulatory pathway. Later data defined a much smaller region for rhy-3(ia30), 
while rhy-S(ia32) has not been mapped any further (Figure 2). However, preliminary data 
and findings gave satisfactory information to test the hypothesis that either of these two 
genes was involved in HIF-1 regulation. 
RNAi data 
chn-1 and ufd-2 feeding RNAi has no effect on nhr-57:GFP expression at 20°C or 
25°C. 
To determine if chn-1 is involved in a pathway as a negative regulator of HIF-1, I 
generated plasmids that would express dsRNA to inactivate the function of chn-1 in L4 
hermaphrodite C. el egans. As shown in table 1, all strains treated with both types of u, fd-2 
RNAi and chn-1 RNAi show a GFP phenotype that is the same as treating the worms with 
empty vector only. There is nearly 100% penetrance of the hif-1 positive control, which 
effectively shows no GFP expression and 83 % of strains treated with shy-1 RNAi show 
greatly increased GFP expression. Penetrance of the RNAi phenotypes does not seem to be 
mediated by strain in these genes. j~hy-1 RNAi served as positive control because it has been 




General conclusions of R.NAi data 
There is a possibility that these two genes might be involved in a novel degradation 
pathway for HIF-1 independent of VHL- l , and that the RNAi phenotypes could not be 
observed using the methods presented here. In a large-scale RNAi screen performed by 
Kamath et al., of 52 genes giving a sterile phenotype by either feeding or injection RNAi, 
52% of the genes were detected only by feeding and 4% of the genes were detected only by 
injection. This evidence lends credence to feeding as a better indicator of R~TAi phenotype, 
but there are a handful of genes that only show an RNAi phenotype by injection. In addition, 
there are gene-specific differences, and I~:NAi feeding can be more variable than injection in 
its results. Another potential drawback to using feeding RNAi is that there are multiple 
protocols and recommendations for reagent usage, concentration, and temperature of 
experiments. while this doesn't seem to have an impact on most genes, it could have an 
impact on whether or not certain genes show ~:NAi phenotypes. 
Despite these caveats, RNAi by feeding has been shown to be more reliable in most 
circumstances than injection or soaking RNAi. Also, it is much less time-intensive, so it 
allows a researcher to do a wide-scale screen using feeding RNAi in a much shorter amount 
of time than if one were doing microinj ection. Over 80% of the C. elegans genome is 
represented in a library of gene fragments cloned into the L4440 vector in HT 115 cells 
(Timmons and Fire 1998). 
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Evidence of vhl-independent mechanism in the regulation of HIF-1 
Data from our lab and from the Ratcliffe lab suggests that there is a vhl-independent 
mechanism in place for the regulation of HIF-1 because HIF-1 target genes are expressed at 
higher levels in an egl-9 deficient background compared to a vhl-1 deficient background 
(Bishop et al. 2004 and Shen, unpublished data). In addition, egl-9 worms have a more 
severe phenotype than vhl-1 worms. During partial genome screens for regulators of HIF-1 
using RNAi, our lab has found that that majority of identified genes causing increased GFP 
expression in strains carrying an integrated GFP are either metabolic or proteasomal in 
nature. The RNAi experiments presented above do not show that chn-1 or ufd 2 are a part of 
this type of regulation, but there are pieces of information suggesting that a similar pathway 
involving other regulators might be acting upon HIF- l . 
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Gene: cdc-48 ufd-2 rhy-1 
Locale: 0.61 0.68 1.06 
(m.u.) 
Figure 1: The relative positions of genes of interest on LG II. Snip-SNP mapping placed 
rhy-5(ia32) in the middle of LG II, and the region encompassed many genes. Three genes of 
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Figure 2: The relative positions of genes on LG I. Snip-SNP mapping placed rhy-3(ia30) in 
the middle of LG I, which encompasses many genes, one of which is chn-1. Other mapping 
techniques narrowed the map position to an area that does not include chn-1 (mapping 
described in chapter 2). 
Strains Worms exhibiting low 
GFP expression at 20°C 
Worms exhibiting low GFP 
expression at 25°C 
ZG120:ials07; vhl-1(ok161) 69/69 91/98 
ZG123: ials07 152/152 345/345 
ZG242: ials07; vhl- 
1(ok161); rNf-3(pk1426) 
135/135 185 
Table 1 A: hif-1 RNAi consistently shows lowered GFP expression in all worm strains. The 
second column represents the proportion of worms that show lowered GFP expression at 
20°C, and the third column represents the proportion of worms that show lowered GFP 
expression at 25°C. This served as a control experiment to show RNAi effects that inhibit 
GFP expression, and it does not depend upon vhl-1 expression. This expression is 
throughout the entire body of the worm. 
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Strains Worms exhibiting high 
GFP expression at 20°C 
Worms exhibiting highGFP 
expression at 25°C 
ZG120:ials07; vhl-1(ok161) 55/57 65/68 
ZG123: ials07 156/178 199/206 
ZG242: ials07; vhl- 
1(ok161); ~Nf-3(pk1426) 
98/104 148/156 
Table 1 B : shy-1 RNAi consistently shows increased GFP expression in all worm strains. 
The second column represents the proportion of worms that show increased GFP expression 
at 20°C, and the third column represents the proportion of worms that show increased GFP 
expression at 25°C. This served as a control experiment to show RN1~.i effects that increases 
GFP expression, and it does not depend upon vhl-1 expression. This expression is 
throughout the entire body of the worm. 
Strains Worms exhibiting no 
difference in GFP 
expression at 20°C 
Worms exhibiting no 
difference in GFP expression 
at 25°C 
ZG120:ials07; vhl-1(ok161) 75/75 169/169 
ZG123: ials07 203/203 283/283 
ZG242: ials07; vhl- 
1(ok161); ~~f-3(pk1426) 
226/226 174/174 
Table 1 C: Treating strains with empty vector (L4440) results in no change in GFP 
expression. All strains treated show no statistical difference in GFP expression, regardless of 
temperature or strain composition. 
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Strains Worms exhibiting no 
difference in GFP 
expression after 
treatment with chn-1 
vector 
Worms exhibiting no 
difference in GFP 
expression after 
treatment with ufd-2A 
vector 
Worms exhibiting no 
difference in GFP 
expression at 









118/118 127/127 117/117 
ZG123:ials07 
20°C 
108/108 212/212 227/227 
ZG123:ials07 
25°C 












150/150 166/166 226/226 
Table 1D: Treatment of strains with ufd-2 and chn-1 RNAi does not change the expression 
of GFP. Each column shows the proportion of worms that show GFP expression that isn't 
changed from the baseline amount of GFP (without any RNAi effect). 
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The transcriptional response to hypoxia in both mammals and C. elegans is largely 
regulated by hypoxia inducible factors (HIFs). A basic pathway has been elucidated in both 
types of organisms, but other pathways involving hypoxia inducible factors are currently 
being researched. This is an important area of research because molecules in the HIF 
pathway have been shown to be involved in heart disease and cancer. To this end, our lab 
has identified numerous candidate genes that maybe negative regulators of HIF-1 in C. 
elegans by using a forward genetic screen. I focused on characterizing one of these genes, 
Yhy-3(ia30). It was found to be between 2.66 and 2.84 map units of chromosome I. The 
other experiment I conducted related to this was determining if HIF-1 was a substrate for 
polyubiquitination by UFD-2 and CHN-l. I utilized RNAi in order to address this issue, and 
determined that HIF-1 is not a substrate for these candidate genes in C. elegans. 
FUTURE RESEARCH 
Further molecular characterization of rhy-3 will be necessary for identifying how this 
gene fits into the HIF-1 pathway. rhy-3(ia30) mutants overexpress GFP in a background 
containing GFP fused to a HIF-1 target gene. It would be helpful to measure the levels of 
other HIF-1 downstream genes in addition to this visual marker. Also, measuring the amount 
of HIF-1 protein present in the shy-3(ia30) mutants would help in fuxther molecular 
characterization. Since shy-3(ia30) has been mapped to a small region of chromosome I, it 
61 
might also be helpful to test known genes in that regions to determine if they are mutable to 
an increased GFP phenotype. 
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